3-(9-(1-((5-chloropyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol | 1208308-08-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 3-(9-(1-((5-chloropyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol
• 英文别名: 3-[9-[1-[(5-chloropyridin-3-yl)methyl]piperidin-4-yl]-6-morpholin-4-ylpurin-2-yl]phenol
• CAS: 1208308-08-0
• 化学式: C₂₆H₂₈ClN₇O₂
• 分子量: 506.007
• InChiKey: FCTIIYYWTWBECW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  36
• 可旋转键数：
  5
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  92.4
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  3-(6-morpholin-4-yl-9-piperidin-4-yl-9H-purin-2-yl)phenol 、 5-氯吡啶-3-甲醛 在 sodium cyanoborohydride 、 zinc(II) chloride 作用下， 以 甲醇 为溶剂， 反应 12.0h， 生成 3-(9-(1-((5-chloropyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol
  参考文献：
  名称：

  Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors

  摘要：

  This article describes the syntheses and SAR of a series of imidazolopyrimidine derivatives, which are evaluated as inhibitors of PI3-Kinase (PI3 K) and mTOR. These compounds were found to be ATP competitive with good tumor cell growth inhibition, and suppression of pathway specific biomakers such as phosphorylation of Akt at T308. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.11.057

文献信息

• Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors
  作者：Aranapakam M. Venkatesan、Christoph M. Dehnhardt、Zecheng Chen、Efren Delos Santos、Osvaldo Dos Santos、Matthew Bursavich、Adam M. Gilbert、John W. Ellingboe、Semiramis Ayral-Kaloustian、Gulnaz Khafizova、Natasja Brooijmans、Robert Mallon、Irwin Hollander、Larry Feldberg、Judy Lucas、Ker Yu、Jay Gibbons、Robert Abraham、Tarek S. Mansour

  DOI：10.1016/j.bmcl.2009.11.057

  日期：2010.1

  This article describes the syntheses and SAR of a series of imidazolopyrimidine derivatives, which are evaluated as inhibitors of PI3-Kinase (PI3 K) and mTOR. These compounds were found to be ATP competitive with good tumor cell growth inhibition, and suppression of pathway specific biomakers such as phosphorylation of Akt at T308. (C) 2009 Elsevier Ltd. All rights reserved.